- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Biologics are all the pharmaceutical products developed using a biological process. Biologic products include drug manufactured from the various living organism with the help of biotechnology. Subcutaneous biologics consists of sugar, nucleic acid, protein or their combination of these substances.
According to our latest study, the global Subcutaneous Biologics market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Subcutaneous Biologics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Subcutaneous Biologics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Subcutaneous Biologics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Subcutaneous Biologics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Subcutaneous Biologics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Subcutaneous Biologics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Subcutaneous Biologics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Pfizer Inc., Genentech Inc., Novartis AG and Biogen Idec, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Subcutaneous Biologics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Syringe
Wearable injector
Automatic injector
Implants
Market segment by Application
Hospital pharmacies
Retail pharmacies
Drug stores
Online pharmacies
Market segment by players, this report covers
Abbott Laboratories
Pfizer Inc.
Genentech Inc.
Novartis AG
Biogen Idec
AbbVie Inc.
F. Hoffmann-La Roche AG
Bristol-Myers Squibb
Eisai Inc.
Takeda Pharmaceuticals Ltd.
Alnylam Pharmaceuticals
Bayer AG
GlaxoSmithKline
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Subcutaneous Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Subcutaneous Biologics, with revenue, gross margin and global market share of Subcutaneous Biologics from 2018 to 2023.
Chapter 3, the Subcutaneous Biologics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Subcutaneous Biologics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Subcutaneous Biologics.
Chapter 13, to describe Subcutaneous Biologics research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Subcutaneous Biologics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Subcutaneous Biologics by Type
1.3.1 Overview: Global Subcutaneous Biologics Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Subcutaneous Biologics Consumption Value Market Share by Type in 2022
1.3.3 Syringe
1.3.4 Wearable injector
1.3.5 Automatic injector
1.3.6 Implants
1.4 Global Subcutaneous Biologics Market by Application
1.4.1 Overview: Global Subcutaneous Biologics Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital pharmacies
1.4.3 Retail pharmacies
1.4.4 Drug stores
1.4.5 Online pharmacies
1.5 Global Subcutaneous Biologics Market Size & Forecast
1.6 Global Subcutaneous Biologics Market Size and Forecast by Region
1.6.1 Global Subcutaneous Biologics Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Subcutaneous Biologics Market Size by Region, (2018-2029)
1.6.3 North America Subcutaneous Biologics Market Size and Prospect (2018-2029)
1.6.4 Europe Subcutaneous Biologics Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Subcutaneous Biologics Market Size and Prospect (2018-2029)
1.6.6 South America Subcutaneous Biologics Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Subcutaneous Biologics Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Subcutaneous Biologics Product and Solutions
2.1.4 Abbott Laboratories Subcutaneous Biologics Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Pfizer Inc.
2.2.1 Pfizer Inc. Details
2.2.2 Pfizer Inc. Major Business
2.2.3 Pfizer Inc. Subcutaneous Biologics Product and Solutions
2.2.4 Pfizer Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pfizer Inc. Recent Developments and Future Plans
2.3 Genentech Inc.
2.3.1 Genentech Inc. Details
2.3.2 Genentech Inc. Major Business
2.3.3 Genentech Inc. Subcutaneous Biologics Product and Solutions
2.3.4 Genentech Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Genentech Inc. Recent Developments and Future Plans
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business
2.4.3 Novartis AG Subcutaneous Biologics Product and Solutions
2.4.4 Novartis AG Subcutaneous Biologics Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novartis AG Recent Developments and Future Plans
2.5 Biogen Idec
2.5.1 Biogen Idec Details
2.5.2 Biogen Idec Major Business
2.5.3 Biogen Idec Subcutaneous Biologics Product and Solutions
2.5.4 Biogen Idec Subcutaneous Biologics Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Biogen Idec Recent Developments and Future Plans
2.6 AbbVie Inc.
2.6.1 AbbVie Inc. Details
2.6.2 AbbVie Inc. Major Business
2.6.3 AbbVie Inc. Subcutaneous Biologics Product and Solutions
2.6.4 AbbVie Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 AbbVie Inc. Recent Developments and Future Plans
2.7 F. Hoffmann-La Roche AG
2.7.1 F. Hoffmann-La Roche AG Details
2.7.2 F. Hoffmann-La Roche AG Major Business
2.7.3 F. Hoffmann-La Roche AG Subcutaneous Biologics Product and Solutions
2.7.4 F. Hoffmann-La Roche AG Subcutaneous Biologics Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 F. Hoffmann-La Roche AG Recent Developments and Future Plans
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business
2.8.3 Bristol-Myers Squibb Subcutaneous Biologics Product and Solutions
2.8.4 Bristol-Myers Squibb Subcutaneous Biologics Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.9 Eisai Inc.
2.9.1 Eisai Inc. Details
2.9.2 Eisai Inc. Major Business
2.9.3 Eisai Inc. Subcutaneous Biologics Product and Solutions
2.9.4 Eisai Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Eisai Inc. Recent Developments and Future Plans
2.10 Takeda Pharmaceuticals Ltd.
2.10.1 Takeda Pharmaceuticals Ltd. Details
2.10.2 Takeda Pharmaceuticals Ltd. Major Business
2.10.3 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Product and Solutions
2.10.4 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Takeda Pharmaceuticals Ltd. Recent Developments and Future Plans
2.11 Alnylam Pharmaceuticals
2.11.1 Alnylam Pharmaceuticals Details
2.11.2 Alnylam Pharmaceuticals Major Business
2.11.3 Alnylam Pharmaceuticals Subcutaneous Biologics Product and Solutions
2.11.4 Alnylam Pharmaceuticals Subcutaneous Biologics Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
2.12 Bayer AG
2.12.1 Bayer AG Details
2.12.2 Bayer AG Major Business
2.12.3 Bayer AG Subcutaneous Biologics Product and Solutions
2.12.4 Bayer AG Subcutaneous Biologics Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Bayer AG Recent Developments and Future Plans
2.13 GlaxoSmithKline
2.13.1 GlaxoSmithKline Details
2.13.2 GlaxoSmithKline Major Business
2.13.3 GlaxoSmithKline Subcutaneous Biologics Product and Solutions
2.13.4 GlaxoSmithKline Subcutaneous Biologics Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 GlaxoSmithKline Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Subcutaneous Biologics Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Subcutaneous Biologics by Company Revenue
3.2.2 Top 3 Subcutaneous Biologics Players Market Share in 2022
3.2.3 Top 6 Subcutaneous Biologics Players Market Share in 2022
3.3 Subcutaneous Biologics Market: Overall Company Footprint Analysis
3.3.1 Subcutaneous Biologics Market: Region Footprint
3.3.2 Subcutaneous Biologics Market: Company Product Type Footprint
3.3.3 Subcutaneous Biologics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Subcutaneous Biologics Consumption Value and Market Share by Type (2018-2023)
4.2 Global Subcutaneous Biologics Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Subcutaneous Biologics Consumption Value Market Share by Application (2018-2023)
5.2 Global Subcutaneous Biologics Market Forecast by Application (2024-2029)
6 North America
6.1 North America Subcutaneous Biologics Consumption Value by Type (2018-2029)
6.2 North America Subcutaneous Biologics Consumption Value by Application (2018-2029)
6.3 North America Subcutaneous Biologics Market Size by Country
6.3.1 North America Subcutaneous Biologics Consumption Value by Country (2018-2029)
6.3.2 United States Subcutaneous Biologics Market Size and Forecast (2018-2029)
6.3.3 Canada Subcutaneous Biologics Market Size and Forecast (2018-2029)
6.3.4 Mexico Subcutaneous Biologics Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Subcutaneous Biologics Consumption Value by Type (2018-2029)
7.2 Europe Subcutaneous Biologics Consumption Value by Application (2018-2029)
7.3 Europe Subcutaneous Biologics Market Size by Country
7.3.1 Europe Subcutaneous Biologics Consumption Value by Country (2018-2029)
7.3.2 Germany Subcutaneous Biologics Market Size and Forecast (2018-2029)
7.3.3 France Subcutaneous Biologics Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Subcutaneous Biologics Market Size and Forecast (2018-2029)
7.3.5 Russia Subcutaneous Biologics Market Size and Forecast (2018-2029)
7.3.6 Italy Subcutaneous Biologics Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Subcutaneous Biologics Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Subcutaneous Biologics Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Subcutaneous Biologics Market Size by Region
8.3.1 Asia-Pacific Subcutaneous Biologics Consumption Value by Region (2018-2029)
8.3.2 China Subcutaneous Biologics Market Size and Forecast (2018-2029)
8.3.3 Japan Subcutaneous Biologics Market Size and Forecast (2018-2029)
8.3.4 South Korea Subcutaneous Biologics Market Size and Forecast (2018-2029)
8.3.5 India Subcutaneous Biologics Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Subcutaneous Biologics Market Size and Forecast (2018-2029)
8.3.7 Australia Subcutaneous Biologics Market Size and Forecast (2018-2029)
9 South America
9.1 South America Subcutaneous Biologics Consumption Value by Type (2018-2029)
9.2 South America Subcutaneous Biologics Consumption Value by Application (2018-2029)
9.3 South America Subcutaneous Biologics Market Size by Country
9.3.1 South America Subcutaneous Biologics Consumption Value by Country (2018-2029)
9.3.2 Brazil Subcutaneous Biologics Market Size and Forecast (2018-2029)
9.3.3 Argentina Subcutaneous Biologics Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Subcutaneous Biologics Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Subcutaneous Biologics Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Subcutaneous Biologics Market Size by Country
10.3.1 Middle East & Africa Subcutaneous Biologics Consumption Value by Country (2018-2029)
10.3.2 Turkey Subcutaneous Biologics Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Subcutaneous Biologics Market Size and Forecast (2018-2029)
10.3.4 UAE Subcutaneous Biologics Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Subcutaneous Biologics Market Drivers
11.2 Subcutaneous Biologics Market Restraints
11.3 Subcutaneous Biologics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Subcutaneous Biologics Industry Chain
12.2 Subcutaneous Biologics Upstream Analysis
12.3 Subcutaneous Biologics Midstream Analysis
12.4 Subcutaneous Biologics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Subcutaneous Biologics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Subcutaneous Biologics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Subcutaneous Biologics Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Subcutaneous Biologics Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 6. Abbott Laboratories Major Business
Table 7. Abbott Laboratories Subcutaneous Biologics Product and Solutions
Table 8. Abbott Laboratories Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Abbott Laboratories Recent Developments and Future Plans
Table 10. Pfizer Inc. Company Information, Head Office, and Major Competitors
Table 11. Pfizer Inc. Major Business
Table 12. Pfizer Inc. Subcutaneous Biologics Product and Solutions
Table 13. Pfizer Inc. Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Pfizer Inc. Recent Developments and Future Plans
Table 15. Genentech Inc. Company Information, Head Office, and Major Competitors
Table 16. Genentech Inc. Major Business
Table 17. Genentech Inc. Subcutaneous Biologics Product and Solutions
Table 18. Genentech Inc. Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Genentech Inc. Recent Developments and Future Plans
Table 20. Novartis AG Company Information, Head Office, and Major Competitors
Table 21. Novartis AG Major Business
Table 22. Novartis AG Subcutaneous Biologics Product and Solutions
Table 23. Novartis AG Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Novartis AG Recent Developments and Future Plans
Table 25. Biogen Idec Company Information, Head Office, and Major Competitors
Table 26. Biogen Idec Major Business
Table 27. Biogen Idec Subcutaneous Biologics Product and Solutions
Table 28. Biogen Idec Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Biogen Idec Recent Developments and Future Plans
Table 30. AbbVie Inc. Company Information, Head Office, and Major Competitors
Table 31. AbbVie Inc. Major Business
Table 32. AbbVie Inc. Subcutaneous Biologics Product and Solutions
Table 33. AbbVie Inc. Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. AbbVie Inc. Recent Developments and Future Plans
Table 35. F. Hoffmann-La Roche AG Company Information, Head Office, and Major Competitors
Table 36. F. Hoffmann-La Roche AG Major Business
Table 37. F. Hoffmann-La Roche AG Subcutaneous Biologics Product and Solutions
Table 38. F. Hoffmann-La Roche AG Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. F. Hoffmann-La Roche AG Recent Developments and Future Plans
Table 40. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 41. Bristol-Myers Squibb Major Business
Table 42. Bristol-Myers Squibb Subcutaneous Biologics Product and Solutions
Table 43. Bristol-Myers Squibb Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Bristol-Myers Squibb Recent Developments and Future Plans
Table 45. Eisai Inc. Company Information, Head Office, and Major Competitors
Table 46. Eisai Inc. Major Business
Table 47. Eisai Inc. Subcutaneous Biologics Product and Solutions
Table 48. Eisai Inc. Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Eisai Inc. Recent Developments and Future Plans
Table 50. Takeda Pharmaceuticals Ltd. Company Information, Head Office, and Major Competitors
Table 51. Takeda Pharmaceuticals Ltd. Major Business
Table 52. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Product and Solutions
Table 53. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Takeda Pharmaceuticals Ltd. Recent Developments and Future Plans
Table 55. Alnylam Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 56. Alnylam Pharmaceuticals Major Business
Table 57. Alnylam Pharmaceuticals Subcutaneous Biologics Product and Solutions
Table 58. Alnylam Pharmaceuticals Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Alnylam Pharmaceuticals Recent Developments and Future Plans
Table 60. Bayer AG Company Information, Head Office, and Major Competitors
Table 61. Bayer AG Major Business
Table 62. Bayer AG Subcutaneous Biologics Product and Solutions
Table 63. Bayer AG Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Bayer AG Recent Developments and Future Plans
Table 65. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 66. GlaxoSmithKline Major Business
Table 67. GlaxoSmithKline Subcutaneous Biologics Product and Solutions
Table 68. GlaxoSmithKline Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. GlaxoSmithKline Recent Developments and Future Plans
Table 70. Global Subcutaneous Biologics Revenue (USD Million) by Players (2018-2023)
Table 71. Global Subcutaneous Biologics Revenue Share by Players (2018-2023)
Table 72. Breakdown of Subcutaneous Biologics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Subcutaneous Biologics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Subcutaneous Biologics Players
Table 75. Subcutaneous Biologics Market: Company Product Type Footprint
Table 76. Subcutaneous Biologics Market: Company Product Application Footprint
Table 77. Subcutaneous Biologics New Market Entrants and Barriers to Market Entry
Table 78. Subcutaneous Biologics Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Subcutaneous Biologics Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Subcutaneous Biologics Consumption Value Share by Type (2018-2023)
Table 81. Global Subcutaneous Biologics Consumption Value Forecast by Type (2024-2029)
Table 82. Global Subcutaneous Biologics Consumption Value by Application (2018-2023)
Table 83. Global Subcutaneous Biologics Consumption Value Forecast by Application (2024-2029)
Table 84. North America Subcutaneous Biologics Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Subcutaneous Biologics Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Subcutaneous Biologics Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Subcutaneous Biologics Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Subcutaneous Biologics Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Subcutaneous Biologics Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Subcutaneous Biologics Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Subcutaneous Biologics Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Subcutaneous Biologics Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Subcutaneous Biologics Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Subcutaneous Biologics Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Subcutaneous Biologics Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Subcutaneous Biologics Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Subcutaneous Biologics Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Subcutaneous Biologics Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Subcutaneous Biologics Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Subcutaneous Biologics Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Subcutaneous Biologics Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Subcutaneous Biologics Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Subcutaneous Biologics Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Subcutaneous Biologics Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Subcutaneous Biologics Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Subcutaneous Biologics Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Subcutaneous Biologics Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Subcutaneous Biologics Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Subcutaneous Biologics Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Subcutaneous Biologics Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Subcutaneous Biologics Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Subcutaneous Biologics Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Subcutaneous Biologics Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Subcutaneous Biologics Raw Material
Table 115. Key Suppliers of Subcutaneous Biologics Raw Materials
List of Figures
Figure 1. Subcutaneous Biologics Picture
Figure 2. Global Subcutaneous Biologics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Subcutaneous Biologics Consumption Value Market Share by Type in 2022
Figure 4. Syringe
Figure 5. Wearable injector
Figure 6. Automatic injector
Figure 7. Implants
Figure 8. Global Subcutaneous Biologics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Subcutaneous Biologics Consumption Value Market Share by Application in 2022
Figure 10. Hospital pharmacies Picture
Figure 11. Retail pharmacies Picture
Figure 12. Drug stores Picture
Figure 13. Online pharmacies Picture
Figure 14. Global Subcutaneous Biologics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Subcutaneous Biologics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Subcutaneous Biologics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Subcutaneous Biologics Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Subcutaneous Biologics Consumption Value Market Share by Region in 2022
Figure 19. North America Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Subcutaneous Biologics Revenue Share by Players in 2022
Figure 25. Subcutaneous Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Subcutaneous Biologics Market Share in 2022
Figure 27. Global Top 6 Players Subcutaneous Biologics Market Share in 2022
Figure 28. Global Subcutaneous Biologics Consumption Value Share by Type (2018-2023)
Figure 29. Global Subcutaneous Biologics Market Share Forecast by Type (2024-2029)
Figure 30. Global Subcutaneous Biologics Consumption Value Share by Application (2018-2023)
Figure 31. Global Subcutaneous Biologics Market Share Forecast by Application (2024-2029)
Figure 32. North America Subcutaneous Biologics Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Subcutaneous Biologics Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Subcutaneous Biologics Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Subcutaneous Biologics Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Subcutaneous Biologics Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Subcutaneous Biologics Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 42. France Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Subcutaneous Biologics Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Subcutaneous Biologics Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Subcutaneous Biologics Consumption Value Market Share by Region (2018-2029)
Figure 49. China Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 52. India Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Subcutaneous Biologics Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Subcutaneous Biologics Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Subcutaneous Biologics Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Subcutaneous Biologics Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Subcutaneous Biologics Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Subcutaneous Biologics Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Subcutaneous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 66. Subcutaneous Biologics Market Drivers
Figure 67. Subcutaneous Biologics Market Restraints
Figure 68. Subcutaneous Biologics Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Subcutaneous Biologics in 2022
Figure 71. Manufacturing Process Analysis of Subcutaneous Biologics
Figure 72. Subcutaneous Biologics Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
